Alert: Federal Executive Order Accelerates Psychedelic Research & Access

A recent U.S. Presidential Executive Order signals significant federal support for psychedelic research and access, focusing on mental health. Key provisions include $50 million in match-funding for state-level research and expanded 'Right-to-Try' access for Schedule I psychedelics, including psilocybin. This executive action creates new avenues for product development and market entry, particularly for state-level initiatives.

U.S. President Signs Psychedelics Executive Order: Signalling federal support for psychedelic research and access, with a focus on mental health, a recent Executive Order (EO) envisages:

$50 million match-funding via ARPA-H to support state-level psychedelic research.
Schedule I Drug Access Through Right-to-Try for patients with life-threatening illnesses.
Commissioner’s National Priority Vouchers to fast-track the evaluation of select psychedelics candidates, including two psilocybin-based candidates and a methylone candidate.

Sentinel Insight